VenoStent

VenoStent develops bioengineered vascular support technology to improve dialysis access outcomes for patients with end-stage renal disease. Their SelfWrap product is a bioabsorbable, flexible vascular wrap designed to reduce dialysis access site failures.

Dialysis access sites have a 50-60% failure rate in the first year, reducing quality of life for end-stage renal disease patients and costing Medicare over $4 billion annually.